drugset / Trial / NCT05916521

A Three Month Bleeding-Model Clinical Study

NCT05916521

Completed 90 enrolled Procter and Gamble
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of the study is to evaluate the gingivitis control benefit of an established stannous fluoride containing toothpaste relative to a negative control dentifrice.

Timeline

Start
2021-11-15
Primary completion
2022-02-11
Completion
2022-02-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator sodium monofluorophosphate Unknown 0.76 % Oral
Comparator stannous fluoride Small molecule 0.454 % Oral

Indications